MAPT and Alzheimer disease: Previous research into the role of SORL1 in AD has indicated that reduced brain levels of SORL1 increase the generation of Aβ by altering the transport of APP, and our finding that SORL1 also increases tau seeding highlights a paradox that lowering SORL1 levels might have both positive and negative effects in the progression of AD.